SCIENCE 37 HOLDINGS INC (SNCE) Stock News

USA - NASDAQ:SNCE - US8086442071 - Common Stock

5.75 USD

+0.02 (+0.35%)

Last: 3/11/2024, 6:05:35 PM

5.7203 USD

-0.03 (-0.52%)

After Hours: 3/11/2024, 6:05:35 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

SNCE Latest News, Press Relases and Analysis

All

Press Releases

25 days ago - By: Science 37, Inc.

Science 37 Completes Third FDA Inspection, Validating Quality of its Direct-to-Patient Site in Pivotal Phase 3 Rare Disease Trial

25 days ago - By: Science 37, Inc.

Science 37 Completes Third FDA Inspection, Validating Quality of its Direct-to-Patient Site in Pivotal Phase 3 Rare Disease Trial

2 months ago - By: Science 37, Inc.

Science 37 and Catalent Announce Partnership Enabling Universal Access to Clinical Research

2 months ago - By: Science 37, Inc.

Science 37 and Catalent Announce Partnership Enabling Universal Access to Clinical Research

2 years ago - By: eMed

eMed commences tender offer for Science 37

7 months ago - By: Science 37, Inc.

Science 37 Completes Second FDA Inspection as Enrollment Leader in Phase 3 Asthma Trial

10 months ago - By: Science 37, Inc.

Science 37 Appoints Tyler Van Horn as CEO to Lead Next Era of Patient-Access Innovation

a year ago - By: Science 37, Inc.

Science 37 Nearly Doubles U.S. Enrollment for GSK Phase 3 Rare Disease Trial

a year ago - By: Science 37, Inc.

Science 37 Nearly Doubles U.S. Enrollment for GSK Phase 3 Rare Disease Trial

a year ago - By: Science 37, Inc.

Science 37 Earns Frost & Sullivan’s 2024 Global Company of the Year Award for Decentralized Clinical Trials

a year ago - By: Science 37, Inc.

Science 37 Unveils New Corporate Headquarters in Research Triangle Park, NC

a year ago - By: Science 37, Inc.

Science 37 Unveils New Corporate Headquarters in Research Triangle Park, NC

a year ago - By: Science 37, Inc.

Science 37 Enrolls 42% of Trial Cohort in 8 Weeks

a year ago - By: Science 37, Inc.

Science 37 Quickly Impacts Performance in Under-Enrolling Clinical Trials

a year ago - By: Science 37, Inc.

Science 37 Quickly Impacts Performance in Under-Enrolling Clinical Trials

a year ago - By: Science 37, Inc.

CORRECTION-- Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial

a year ago - By: Science 37, Inc.

CORRECTION-- Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial

a year ago - By: Science 37, Inc.

Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial

a year ago - By: Science 37, Inc.

Science 37 Metasite™ Undergoes Successful FDA Inspection, Marking Major Milestone in Virtual Site Quality Assurance and Compliance

1 years ago - By: Science 37, Inc.

Science 37 Wins 2024 MedTech Breakthrough Award for “Clinical Efficiency Innovation”

1 years ago - By: Science 37, Inc.

Science 37 Wins 2024 MedTech Breakthrough Award for “Clinical Efficiency Innovation”

2 years ago - By: Science 37, Inc.

Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical Trial

2 years ago - By: Science 37, Inc.

Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical Trial

2 years ago - By: Science 37, Inc.

Science 37 Provides Fully Consented Patients to Sites to Supplement Enrollment

2 years ago - By: eMed

eMed completes tender offer for all outstanding shares of Science 37

2 years ago - By: Kahn Swick & Foti, LLC

SCIENCE 37 HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Science 37 Holdings, Inc. - SNCE

2 years ago - By: Kahn Swick & Foti, LLC

SCIENCE 37 HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Science 37 Holdings, Inc. - SNCE

2 years ago - By: Ademi LLP

Shareholder Alert: Ademi LLP investigates whether Science 37 Holdings, Inc. has obtained a Fair Price in its transaction with eMed

2 years ago - By: Benzinga - Mentions: SOFI BE CDLX PBLA ...

Crude Oil Down Over 1%; Science 37 Holdings Shares Spike Higher

2 years ago - By: Benzinga - Mentions: JZ BE SLNA EOLS ...

Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Session

2 years ago - By: Halper Sadeh LLC

SNCE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Science 37 Holdings, Inc. Is Fair to Shareholders

2 years ago - By: Brodsky & Smith LLC - Mentions: ABBV EGLE MGRC CERE ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: McGrath RentCorp (Nasdaq – MGRC), Science 37 Holdings, Inc. (Nasdaq – SNCE), Eagle Bulk Shipping Inc. (NYSE - EGLE), Cerevel Therapeutics Holdings, Inc. (Nasdaq –

2 years ago - By: Science 37, Inc.

Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating Enrollment

2 years ago - By: Science 37, Inc.

Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating Enrollment